Reduced handgrip strength predicts poorer survival in chronic liver diseases: A large multicenter study in Japan

Aim Sarcopenia has a high prevalence and can be an adverse predictor in patients with chronic liver diseases (CLDs). We sought to assess the prevalence of sarcopenia and its prognostic significance in patients with CLDs at multiple centers in Japan. Methods In this retrospective study, we collated t...

Full description

Saved in:
Bibliographic Details
Published inHepatology research Vol. 51; no. 9; pp. 957 - 967
Main Authors Nishikawa, Hiroki, Shiraki, Makoto, Hiramatsu, Akira, Hara, Nagisa, Moriya, Kyoji, Hino, Keisuke, Koike, Kazuhiko
Format Journal Article
LanguageEnglish
Published Hoboken Wiley Subscription Services, Inc 01.09.2021
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Aim Sarcopenia has a high prevalence and can be an adverse predictor in patients with chronic liver diseases (CLDs). We sought to assess the prevalence of sarcopenia and its prognostic significance in patients with CLDs at multiple centers in Japan. Methods In this retrospective study, we collated the data of 1624 patients with CLDs (976 men). The diagnosis of sarcopenia was determined by the sarcopenia assessment criteria of the Japan Society of Hepatology. Predictors of mortality were identified using univariate and multivariate analyses. Results Muscle weakness and skeletal muscle loss occurred in 33.5% and 29.3% of all subjects, respectively, while sarcopenia occurred in 13.9% of all patients. Patients with sarcopenia had a poorer prognosis among all patients, patients with hepatocellular carcinoma (HCC), and those without HCC by log‐rank test. The multivariate Cox proportional hazards model identified female gender (hazard ratio [HR], 0.59; p = 0.03), alcoholic liver disease (HR, 4.25; p < 0.01), presence of HCC (HR, 6.77; p < 0.01), Child–Pugh classes A (HR, 1.42; p < 0.05), B (HR, 2.70; p < 0.01), and C (HR, 6.30; p < 0.01), and muscle weakness (HR, 2.24; p < 0.01) as significant adverse predictors. The cut‐off values of handgrip strength (HGS) for prognosis determined by maximally selected rank statistics were calculated as 27.8 kg for men and 18.8 kg for women. Conclusion Reduced HGS in patients with CLD was an independent adverse predictor of mortality, with cut‐off values of 27.8 kg for men and 18.8 kg for women.
AbstractList Aim Sarcopenia has a high prevalence and can be an adverse predictor in patients with chronic liver diseases (CLDs). We sought to assess the prevalence of sarcopenia and its prognostic significance in patients with CLDs at multiple centers in Japan. Methods In this retrospective study, we collated the data of 1624 patients with CLDs (976 men). The diagnosis of sarcopenia was determined by the sarcopenia assessment criteria of the Japan Society of Hepatology. Predictors of mortality were identified using univariate and multivariate analyses. Results Muscle weakness and skeletal muscle loss occurred in 33.5% and 29.3% of all subjects, respectively, while sarcopenia occurred in 13.9% of all patients. Patients with sarcopenia had a poorer prognosis among all patients, patients with hepatocellular carcinoma (HCC), and those without HCC by log‐rank test. The multivariate Cox proportional hazards model identified female gender (hazard ratio [HR], 0.59; p = 0.03), alcoholic liver disease (HR, 4.25; p < 0.01), presence of HCC (HR, 6.77; p < 0.01), Child–Pugh classes A (HR, 1.42; p < 0.05), B (HR, 2.70; p < 0.01), and C (HR, 6.30; p < 0.01), and muscle weakness (HR, 2.24; p < 0.01) as significant adverse predictors. The cut‐off values of handgrip strength (HGS) for prognosis determined by maximally selected rank statistics were calculated as 27.8 kg for men and 18.8 kg for women. Conclusion Reduced HGS in patients with CLD was an independent adverse predictor of mortality, with cut‐off values of 27.8 kg for men and 18.8 kg for women.
Sarcopenia has a high prevalence and can be an adverse predictor in patients with chronic liver diseases (CLDs). We sought to assess the prevalence of sarcopenia and its prognostic significance in patients with CLDs at multiple centers in Japan.AIMSarcopenia has a high prevalence and can be an adverse predictor in patients with chronic liver diseases (CLDs). We sought to assess the prevalence of sarcopenia and its prognostic significance in patients with CLDs at multiple centers in Japan.In this retrospective study, we collated the data of 1624 patients with CLDs (976 men). The diagnosis of sarcopenia was determined by the sarcopenia assessment criteria of the Japan Society of Hepatology. Predictors of mortality were identified using univariate and multivariate analyses.METHODSIn this retrospective study, we collated the data of 1624 patients with CLDs (976 men). The diagnosis of sarcopenia was determined by the sarcopenia assessment criteria of the Japan Society of Hepatology. Predictors of mortality were identified using univariate and multivariate analyses.Muscle weakness and skeletal muscle loss occurred in 33.5% and 29.3% of all subjects, respectively, while sarcopenia occurred in 13.9% of all patients. Patients with sarcopenia had a poorer prognosis among all patients, patients with hepatocellular carcinoma (HCC), and those without HCC by log-rank test. The multivariate Cox proportional hazards model identified female gender (hazard ratio [HR], 0.59; p = 0.03), alcoholic liver disease (HR, 4.25; p < 0.01), presence of HCC (HR, 6.77; p < 0.01), Child-Pugh classes A (HR, 1.42; p < 0.05), B (HR, 2.70; p < 0.01), and C (HR, 6.30; p < 0.01), and muscle weakness (HR, 2.24; p < 0.01) as significant adverse predictors. The cut-off values of handgrip strength (HGS) for prognosis determined by maximally selected rank statistics were calculated as 27.8 kg for men and 18.8 kg for women.RESULTSMuscle weakness and skeletal muscle loss occurred in 33.5% and 29.3% of all subjects, respectively, while sarcopenia occurred in 13.9% of all patients. Patients with sarcopenia had a poorer prognosis among all patients, patients with hepatocellular carcinoma (HCC), and those without HCC by log-rank test. The multivariate Cox proportional hazards model identified female gender (hazard ratio [HR], 0.59; p = 0.03), alcoholic liver disease (HR, 4.25; p < 0.01), presence of HCC (HR, 6.77; p < 0.01), Child-Pugh classes A (HR, 1.42; p < 0.05), B (HR, 2.70; p < 0.01), and C (HR, 6.30; p < 0.01), and muscle weakness (HR, 2.24; p < 0.01) as significant adverse predictors. The cut-off values of handgrip strength (HGS) for prognosis determined by maximally selected rank statistics were calculated as 27.8 kg for men and 18.8 kg for women.Reduced HGS in patients with CLD was an independent adverse predictor of mortality, with cut-off values of 27.8 kg for men and 18.8 kg for women.CONCLUSIONReduced HGS in patients with CLD was an independent adverse predictor of mortality, with cut-off values of 27.8 kg for men and 18.8 kg for women.
AimSarcopenia has a high prevalence and can be an adverse predictor in patients with chronic liver diseases (CLDs). We sought to assess the prevalence of sarcopenia and its prognostic significance in patients with CLDs at multiple centers in Japan.MethodsIn this retrospective study, we collated the data of 1624 patients with CLDs (976 men). The diagnosis of sarcopenia was determined by the sarcopenia assessment criteria of the Japan Society of Hepatology. Predictors of mortality were identified using univariate and multivariate analyses.ResultsMuscle weakness and skeletal muscle loss occurred in 33.5% and 29.3% of all subjects, respectively, while sarcopenia occurred in 13.9% of all patients. Patients with sarcopenia had a poorer prognosis among all patients, patients with hepatocellular carcinoma (HCC), and those without HCC by log‐rank test. The multivariate Cox proportional hazards model identified female gender (hazard ratio [HR], 0.59; p = 0.03), alcoholic liver disease (HR, 4.25; p < 0.01), presence of HCC (HR, 6.77; p < 0.01), Child–Pugh classes A (HR, 1.42; p < 0.05), B (HR, 2.70; p < 0.01), and C (HR, 6.30; p < 0.01), and muscle weakness (HR, 2.24; p < 0.01) as significant adverse predictors. The cut‐off values of handgrip strength (HGS) for prognosis determined by maximally selected rank statistics were calculated as 27.8 kg for men and 18.8 kg for women.ConclusionReduced HGS in patients with CLD was an independent adverse predictor of mortality, with cut‐off values of 27.8 kg for men and 18.8 kg for women.
Author Hara, Nagisa
Shiraki, Makoto
Hiramatsu, Akira
Hino, Keisuke
Koike, Kazuhiko
Nishikawa, Hiroki
Moriya, Kyoji
Author_xml – sequence: 1
  givenname: Hiroki
  orcidid: 0000-0003-3489-2740
  surname: Nishikawa
  fullname: Nishikawa, Hiroki
  organization: Hyogo College of Medicine
– sequence: 2
  givenname: Makoto
  surname: Shiraki
  fullname: Shiraki, Makoto
  email: mshiraki-gif@umin.ac.jp
  organization: Gifu University Graduate School of Medicine
– sequence: 3
  givenname: Akira
  surname: Hiramatsu
  fullname: Hiramatsu, Akira
  organization: Hiroshima University
– sequence: 4
  givenname: Nagisa
  surname: Hara
  fullname: Hara, Nagisa
  organization: Mie University Hospital
– sequence: 5
  givenname: Kyoji
  surname: Moriya
  fullname: Moriya, Kyoji
  organization: The University of Tokyo
– sequence: 6
  givenname: Keisuke
  orcidid: 0000-0002-3297-1720
  surname: Hino
  fullname: Hino, Keisuke
  organization: Kawasaki Medical School
– sequence: 7
  givenname: Kazuhiko
  surname: Koike
  fullname: Koike, Kazuhiko
  organization: The University of Tokyo
BookMark eNp9kMFq3DAQhkVJoUnaS59A0EspOJmRbNnuLYS0aQgkhBR6M7I83lXQSq4kb9i3r7fbUyiZywzM9w3Df8KOfPDE2EeEM1zqfE1TPEOp6vYNO8amFgXI8tfRMstGFUqW6h07SekJAGsQ5TGbHmiYDQ18rf2winbiKUfyq7zmU6TBmpz4FEKkyNMct3arHbeem3UM3hru7HbZDDaRTpS-8gvudFwR38wuW0M-7708D7u9dKMn7d-zt6N2iT7866fs57erx8vr4vbu-4_Li9vClAraQvVGGNKVrgajSt22PVGNUkJretSjbABJoKC-HFscsRyBxn6sG6xRYCWMPGWfD3enGH7PlHK3scmQc9pTmFMnKlkh1ABqQT-9QJ_CHP3y3UKpBkBAUy7UlwNlYkgp0thN0W503HUI3T78bh9-9zf8BYYXsLFZZxt8jtq6_yt4UJ6to90rx7vrq_uHg_MHQLia-g
CitedBy_id crossref_primary_10_1093_postmj_qgad097
crossref_primary_10_1111_jhn_13160
crossref_primary_10_1038_s41598_023_28528_w
crossref_primary_10_1097_MEG_0000000000002536
crossref_primary_10_3390_life11090899
crossref_primary_10_1111_hepr_14084
crossref_primary_10_3390_diagnostics15030263
crossref_primary_10_1007_s00595_024_02970_3
crossref_primary_10_1111_hepr_13911
crossref_primary_10_1007_s10147_024_02539_7
crossref_primary_10_1002_jgh3_70124
crossref_primary_10_3390_medicina59122099
crossref_primary_10_1111_jgh_16806
crossref_primary_10_3390_nu16244422
crossref_primary_10_1002_cam4_6783
crossref_primary_10_1002_poh2_50
crossref_primary_10_1007_s00535_024_02160_5
crossref_primary_10_1111_hepr_13904
crossref_primary_10_3390_diagnostics13071245
crossref_primary_10_1007_s10147_023_02466_z
crossref_primary_10_3390_nu14224855
crossref_primary_10_3389_fmed_2023_1212899
crossref_primary_10_3389_fnut_2024_1292834
crossref_primary_10_3390_jcm11082079
crossref_primary_10_3390_cancers15061834
crossref_primary_10_5946_ce_2022_278
crossref_primary_10_2957_kanzo_65_559
crossref_primary_10_1007_s00520_022_06983_x
crossref_primary_10_3390_diagnostics13132218
crossref_primary_10_1002_ags3_12897
crossref_primary_10_1002_jhbp_1164
crossref_primary_10_1038_s41598_024_57342_1
crossref_primary_10_23876_j_krcp_21_278
crossref_primary_10_1111_hepr_14179
crossref_primary_10_3390_cancers15123243
crossref_primary_10_1111_hepr_13816
crossref_primary_10_1111_hepr_13959
crossref_primary_10_1016_j_jceh_2023_03_012
crossref_primary_10_1002_jgh3_12702
crossref_primary_10_1002_jgh3_12900
crossref_primary_10_1097_MEG_0000000000002435
crossref_primary_10_1371_journal_pone_0299313
crossref_primary_10_3390_diagnostics11071262
crossref_primary_10_1007_s00535_022_01923_2
crossref_primary_10_2169_internalmedicine_0212_22
crossref_primary_10_1186_s12876_023_02835_y
crossref_primary_10_1186_s12889_023_15749_x
Cites_doi 10.1016/j.nut.2004.02.002
10.1007/s00535-016-1216-y
10.2307/2532740
10.1002/lt.25598
10.1038/387083a0
10.1016/j.clnu.2010.09.010
10.1016/j.clnu.2005.01.002
10.1002/lt.23495
10.1007/s12072-017-9799-9
10.1016/j.exger.2015.05.003
10.1016/j.nut.2017.04.003
10.1007/s11011-013-9377-3
10.1007/BF02820426
10.3390/diagnostics10060433
10.1016/S1542-3565(05)00017-0
10.1111/hepr.13420
10.1093/ajcn/50.5.1231
10.1093/ageing/afq034
10.1097/MCO.0000000000000202
10.1111/hepr.12774
10.1097/MEG.0000000000001415
10.1016/j.jamda.2019.12.012
10.1213/ANE.0b013e3181eac1c9
10.1016/j.jamda.2013.11.025
10.1152/ajpendo.00183.2012
10.1002/hep.27717
10.1016/S0168-8278(97)80315-7
10.1097/00075197-200301000-00012
10.1007/s00535-014-0964-9
10.1016/j.jhep.2016.06.007
10.1093/gerona/glu246
10.1111/hepr.12873
10.7600/jpfsm.4.111
10.1007/s12603-019-1287-6
10.1016/j.jhep.2016.07.040
10.1038/ctg.2015.31
10.1016/j.ejrad.2018.01.025
10.1038/ctg.2016.33
10.1016/j.clnu.2019.04.023
10.1002/jcsm.12212
10.1371/journal.pone.0186990
10.1016/j.bbrc.2003.07.016
10.1016/j.jhep.2015.02.031
10.1007/s13539-012-0069-3
ContentType Journal Article
Copyright 2021 The Japan Society of Hepatology.
Copyright_xml – notice: 2021 The Japan Society of Hepatology.
DBID AAYXX
CITATION
7T5
7TM
7U9
H94
7X8
DOI 10.1111/hepr.13679
DatabaseName CrossRef
Immunology Abstracts
Nucleic Acids Abstracts
Virology and AIDS Abstracts
AIDS and Cancer Research Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
AIDS and Cancer Research Abstracts
Immunology Abstracts
Virology and AIDS Abstracts
Nucleic Acids Abstracts
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
AIDS and Cancer Research Abstracts
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1872-034X
EndPage 967
ExternalDocumentID 10_1111_hepr_13679
HEPR13679
Genre article
GeographicLocations Japan
GeographicLocations_xml – name: Japan
GroupedDBID ---
--K
.3N
.GA
.Y3
05W
0R~
10A
1B1
1OC
1~5
29I
31~
33P
3SF
4.4
4G.
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5VS
66C
7-5
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAEDT
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AALRI
AAMNL
AANHP
AANLZ
AAONW
AAQFI
AAQXK
AASGY
AAXRX
AAXUO
AAYCA
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABIJN
ABJNI
ABPVW
ABQWH
ABWVN
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFO
ACGFS
ACGOF
ACIUM
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACUHS
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADMUD
ADNMO
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFWVQ
AFZJQ
AHBTC
AIACR
AIAGR
AITUG
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EBD
EBS
EJD
ESX
EX3
F00
F01
F04
F5P
FDB
FEDTE
FGOYB
FUBAC
G-Q
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZ~
IHE
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M41
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
NQ-
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
Q.N
Q11
QB0
R.K
R2-
RIG
ROL
RPZ
RX1
SEW
SSZ
SUPJJ
TEORI
TUS
UB1
UHS
V8K
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WRC
WVDHM
WXI
WXSBR
XG1
ZZTAW
~IA
~WT
AAYXX
ACVFH
ADCNI
AEUPX
AEYWJ
AFPUW
AGHNM
AGQPQ
AGYGG
AIGII
CITATION
7T5
7TM
7U9
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
H94
7X8
ID FETCH-LOGICAL-c4609-6bc2cea5a5dc64a99bee713309cb1af3801e212eb4f91f14f0efbf781712152c3
IEDL.DBID DR2
ISSN 1386-6346
IngestDate Fri Jul 11 16:48:56 EDT 2025
Fri Jul 25 04:08:30 EDT 2025
Tue Jul 01 01:58:24 EDT 2025
Thu Apr 24 22:52:21 EDT 2025
Wed Jan 22 16:27:55 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 9
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4609-6bc2cea5a5dc64a99bee713309cb1af3801e212eb4f91f14f0efbf781712152c3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0003-3489-2740
0000-0002-3297-1720
OpenAccessLink https://onlinelibrary.wiley.com/doi/pdf/10.1111/hepr.13679
PQID 2568002084
PQPubID 2045151
PageCount 11
ParticipantIDs proquest_miscellaneous_2535107006
proquest_journals_2568002084
crossref_primary_10_1111_hepr_13679
crossref_citationtrail_10_1111_hepr_13679
wiley_primary_10_1111_hepr_13679_HEPR13679
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate September 2021
PublicationDateYYYYMMDD 2021-09-01
PublicationDate_xml – month: 09
  year: 2021
  text: September 2021
PublicationDecade 2020
PublicationPlace Hoboken
PublicationPlace_xml – name: Hoboken
PublicationTitle Hepatology research
PublicationYear 2021
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References 2017; 8
2017; 41
2015; 6
2015; 4
2013; 28
2015; 18
2019; 31
2015; 70
2017; 47
2010; 39
2015; 50
2018; 101
2004; 89
2020; 39
2011; 30
2005; 21
2016; 51
1997; 27
2012; 18
2020; 10
2012; 303
2012; 11
2005; 24
1989; 50
2015; 69
2016; 7
2012; 3
2004; 313
2015; 61
2003; 6
2017; 11
2015; 63
1997; 387
2019; 25
2017; 12
2016; 65
2010; 111
2014; 15
2019; 49
1981; 16
2020; 24
1992; 48
2005; 3
2020; 21
2016; 46
e_1_2_8_28_1
e_1_2_8_29_1
e_1_2_8_24_1
e_1_2_8_47_1
e_1_2_8_25_1
e_1_2_8_46_1
e_1_2_8_26_1
e_1_2_8_27_1
Mahalakshmi VN (e_1_2_8_18_1) 2004; 89
e_1_2_8_3_1
e_1_2_8_2_1
e_1_2_8_5_1
e_1_2_8_4_1
e_1_2_8_7_1
e_1_2_8_6_1
e_1_2_8_9_1
e_1_2_8_8_1
e_1_2_8_20_1
e_1_2_8_43_1
e_1_2_8_21_1
e_1_2_8_42_1
e_1_2_8_22_1
e_1_2_8_23_1
e_1_2_8_44_1
e_1_2_8_41_1
e_1_2_8_40_1
e_1_2_8_17_1
e_1_2_8_39_1
e_1_2_8_19_1
e_1_2_8_13_1
e_1_2_8_36_1
e_1_2_8_14_1
e_1_2_8_35_1
e_1_2_8_15_1
e_1_2_8_38_1
e_1_2_8_16_1
e_1_2_8_37_1
Mitchell WK (e_1_2_8_45_1) 2012; 11
e_1_2_8_32_1
e_1_2_8_10_1
e_1_2_8_31_1
e_1_2_8_11_1
e_1_2_8_34_1
e_1_2_8_12_1
e_1_2_8_33_1
e_1_2_8_30_1
References_xml – volume: 18
  start-page: 1209
  year: 2012
  end-page: 16
  article-title: Severe muscle depletion in patients on the liver transplant wait list: its prevalence and independent prognostic value
  publication-title: Liver Transplant
– volume: 7
  year: 2016
  article-title: Muscle at risk: the multiple impacts of ammonia on sarcopenia and frailty in cirrhosis
  publication-title: Clin Transl Gastroenterol
– volume: 30
  start-page: 135
  year: 2011
  end-page: 42
  article-title: Hand grip strength: outcome predictor and marker of nutritional status
  publication-title: Clin Nutr
– volume: 70
  start-page: 779
  year: 2015
  end-page: 84
  article-title: Association of low lean mass with frailty and physical performance: a comparison between two operational definitions of sarcopenia–data from the Berlin Aging Study II (BASE‐II)
  publication-title: J Gerontol A Biol Sci Med Sci.
– volume: 46
  start-page: 951
  year: 2016
  end-page: 63
  article-title: Japan Society of Hepatology guidelines for sarcopenia in liver disease (1st edition): recommendation from the working group for creation of sarcopenia assessment criteria
  publication-title: Hepatol Res
– volume: 31
  start-page: 1408
  year: 2019
  end-page: 13
  article-title: Relationship between pre‐sarcopenia and quality of life in patients with chronic liver disease: a cross‐sectional study
  publication-title: Eur J Gastroenterol Hepatol
– volume: 24
  start-page: 125
  year: 2020
  end-page: 6
  article-title: Letter to the editor: normative data of handgrip strength in 26344 older adults–a pooled dataset from eight cohorts in Asia
  publication-title: J Nutr Health Aging
– volume: 69
  start-page: 103
  year: 2015
  end-page: 10
  article-title: Quality of life and physical components linked to sarcopenia: the SarcoPhAge study
  publication-title: Exp Gerontol
– volume: 313
  start-page: 405
  year: 2004
  end-page: 9
  article-title: Branched‐ chain amino acids as a protein‐ and energy‐source in liver cirrhosis
  publication-title: Biochem Biophys Res Commun
– volume: 11
  start-page: 317
  year: 2017
  end-page: 70
  article-title: Asia‐Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update
  publication-title: Hepatol Int
– volume: 111
  start-page: 707
  year: 2010
  end-page: 9
  article-title: Brief‐reports: elevated myostatin levels in patients with liver disease: a potential contributor to skeletal muscle wasting
  publication-title: Anesth Analg
– volume: 8
  start-page: 915
  year: 2017
  end-page: 25
  article-title: Elevated serum myostatin level is associated with worse survival in patients with liver cirrhosis
  publication-title: J Cachexia Sarcopenia Muscle
– volume: 27
  start-page: 796
  year: 1997
  end-page: 802
  article-title: Growth hormone‐stimulated insulin‐like growth factor (IGF) I and IGF‐binding protein‐3 in liver cirrhosis
  publication-title: J Hepatol
– volume: 15
  start-page: 95
  year: 2014
  end-page: 101
  article-title: Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia
  publication-title: J Am Med Dir Assoc
– volume: 3
  start-page: 705
  year: 2005
  end-page: 13
  article-title: Effects of oral branched‐chain amino acid granules on event‐free survival in patients with liver cirrhosis
  publication-title: Clin Gastroenterol Hepatol
– volume: 387
  start-page: 83
  year: 1997
  end-page: 90
  article-title: Regulation of skeletal muscle mass in mice by a new TGF‐beta superfamily member
  publication-title: Nature
– volume: 101
  start-page: 72
  year: 2018
  end-page: 81
  article-title: Diagnosis and staging of hepatocellular carcinoma (HCC): current guidelines
  publication-title: Eur J Radiol
– volume: 16
  start-page: 64
  year: 1981
  end-page: 70
  article-title: Augmented utilization of branched‐chain amino acids by skeletal muscle in decompensated liver cirrhosis in special relation to ammonia detoxication
  publication-title: Gastroenterol Jpn
– volume: 41
  start-page: 80
  year: 2017
  end-page: 5
  article-title: Branched‐chain amino acid supplementation in treatment of liver cirrhosis: updated views on how to attenuate their harmful effects on cataplerosis and ammonia formation
  publication-title: Nutrition
– volume: 61
  start-page: 2018
  year: 2015
  end-page: 29
  article-title: Metabolic and molecular responses to leucine‐enriched branched chain amino acid supplementation in the skeletal muscle of alcoholic cirrhosis
  publication-title: Hepatology
– volume: 18
  start-page: 465
  year: 2015
  end-page: 70
  article-title: Muscle strength: clinical and prognostic value of hand‐grip dynamometry
  publication-title: Curr Opin Clin Nutr Metab Care
– volume: 25
  start-page: 1480
  year: 2019
  end-page: 7
  article-title: Handgrip strength adds more prognostic value to the model for end‐stage liver disease score than imaging‐based measures of muscle mass in men with cirrhosis
  publication-title: Liver Transplant
– volume: 65
  start-page: 1232
  year: 2016
  end-page: 44
  article-title: Sarcopenia from mechanism to diagnosis and treatment in liver disease
  publication-title: J Hepatol
– volume: 89
  start-page: 115
  year: 2004
  end-page: 21
  article-title: Handgrip strength and endurance as a predictor of postoperative morbidity in surgical patients: can it serve as a simple bedside test?
  publication-title: Int Surg
– volume: 10
  start-page: 433
  year: 2020
  article-title: Anthropometric measurements and frailty in patients with liver diseases
  publication-title: Diagnostics
– volume: 6
  year: 2015
  article-title: Inclusion of sarcopenia within MELD (MELD‐Sarcopenia) and the prediction of mortality in patients with cirrhosis
  publication-title: Clin Transl Gastroenterol
– volume: 303
  start-page: E983
  year: 2012
  end-page: 93
  article-title: Hyperammonemia‐mediated autophagy in skeletal muscle contributes to sarcopenia of cirrhosis
  publication-title: Am J Physiol Endocrinol Metab
– volume: 21
  start-page: 113
  year: 2005
  end-page: 7
  article-title: Comparison between handgrip strength, subjective global assessment, and prognostic nutritional index in assessing malnutrition and predicting clinical outcome in cirrhotic outpatients
  publication-title: Nutrition
– volume: 39
  start-page: 1124
  year: 2020
  end-page: 30
  article-title: Low muscle mass and low muscle strength associate with nonalcoholic fatty liver disease
  publication-title: Clin Nutr
– volume: 49
  start-page: 1414
  year: 2019
  end-page: 26
  article-title: Reduced handgrip strength is predictive of poor survival among patients with liver cirrhosis: a sex‐stratified analysis
  publication-title: Hepatol Res
– volume: 47
  start-page: 1359
  year: 2017
  end-page: 67
  article-title: Sarcopenia predicts minimal hepatic encephalopathy in patients with liver cirrhosis
  publication-title: Hepatol Res
– volume: 12
  year: 2017
  article-title: Prognostic value of sarcopenia in patients with liver cirrhosis: a systematic review and meta‐analysis
  publication-title: PloS One
– volume: 48
  start-page: 73
  year: 1992
  end-page: 85
  article-title: Maximally selected rank statistics
  publication-title: Biometrics
– volume: 50
  start-page: 1231
  year: 1989
  end-page: 3
  article-title: Summary comments: epidemiological and methodological problems in determining nutritional status of older persons
  publication-title: Am J Clin Nutr
– volume: 4
  year: 2015
  article-title: Epidemiology of sarcopenia in elderly Japanese
  publication-title: J Phys Fitness Sports Med
– volume: 65
  start-page: 906
  year: 2016
  end-page: 13
  article-title: Testosterone therapy increases muscle mass in men with cirrhosis and low testosterone: a randomised controlled trial
  publication-title: J Hepatol
– volume: 3
  start-page: 225
  year: 2012
  end-page: 37
  article-title: Consilience in sarcopenia of cirrhosis
  publication-title: J Cachexia Sarcopenia Muscle
– volume: 21
  start-page: 300
  year: 2020
  end-page: 7
  article-title: Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment
  publication-title: Am Med Dir Assoc.
– volume: 39
  start-page: 412
  year: 2010
  end-page: 23
  article-title: Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People
  publication-title: Age Ageing
– volume: 50
  start-page: 323
  year: 2015
  end-page: 32
  article-title: Skeletal muscle depletion is an independent prognostic factor for hepatocellular carcinoma
  publication-title: J Gastroenterol
– volume: 51
  start-page: 629
  year: 2016
  end-page: 50
  article-title: Evidence‐based clinical practice guidelines for liver cirrhosis 2015
  publication-title: J Gastroenterol
– volume: 63
  start-page: 131
  year: 2015
  end-page: 40
  article-title: Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma
  publication-title: J Hepatol
– volume: 24
  start-page: 421
  year: 2005
  end-page: 6
  article-title: Relationships between structural and functional measures of nutritional status in a normally nourished population
  publication-title: Clin Nutr
– volume: 6
  start-page: 79
  year: 2003
  end-page: 85
  article-title: Protein metabolism in liver cirrhosis: from albumin to muscle myofibrils
  publication-title: Curr Opin Clin Nutr Metab Care
– volume: 28
  start-page: 217
  year: 2013
  end-page: 20
  article-title: Branched‐chain amino acids and muscle ammonia detoxification in cirrhosis
  publication-title: Metab Brain Dis
– volume: 11
  start-page: 260
  year: 2012
  article-title: Sarcopenia, dynapenia, and the impact of advancing age on human skeletal muscle size and strength; a quantitative review
  publication-title: Front Physiol
– ident: e_1_2_8_16_1
  doi: 10.1016/j.nut.2004.02.002
– ident: e_1_2_8_30_1
  doi: 10.1007/s00535-016-1216-y
– ident: e_1_2_8_33_1
  doi: 10.2307/2532740
– volume: 11
  start-page: 260
  year: 2012
  ident: e_1_2_8_45_1
  article-title: Sarcopenia, dynapenia, and the impact of advancing age on human skeletal muscle size and strength; a quantitative review
  publication-title: Front Physiol
– volume: 89
  start-page: 115
  year: 2004
  ident: e_1_2_8_18_1
  article-title: Handgrip strength and endurance as a predictor of postoperative morbidity in surgical patients: can it serve as a simple bedside test?
  publication-title: Int Surg
– ident: e_1_2_8_20_1
  doi: 10.1002/lt.25598
– ident: e_1_2_8_10_1
  doi: 10.1038/387083a0
– ident: e_1_2_8_17_1
  doi: 10.1016/j.clnu.2010.09.010
– ident: e_1_2_8_15_1
  doi: 10.1016/j.clnu.2005.01.002
– ident: e_1_2_8_28_1
  doi: 10.1002/lt.23495
– ident: e_1_2_8_32_1
  doi: 10.1007/s12072-017-9799-9
– ident: e_1_2_8_3_1
  doi: 10.1016/j.exger.2015.05.003
– ident: e_1_2_8_43_1
  doi: 10.1016/j.nut.2017.04.003
– ident: e_1_2_8_40_1
  doi: 10.1007/s11011-013-9377-3
– ident: e_1_2_8_9_1
  doi: 10.1007/BF02820426
– ident: e_1_2_8_23_1
  doi: 10.3390/diagnostics10060433
– ident: e_1_2_8_42_1
  doi: 10.1016/S1542-3565(05)00017-0
– ident: e_1_2_8_22_1
  doi: 10.1111/hepr.13420
– ident: e_1_2_8_2_1
  doi: 10.1093/ajcn/50.5.1231
– ident: e_1_2_8_5_1
  doi: 10.1093/ageing/afq034
– ident: e_1_2_8_19_1
  doi: 10.1097/MCO.0000000000000202
– ident: e_1_2_8_13_1
  doi: 10.1111/hepr.12774
– ident: e_1_2_8_25_1
  doi: 10.1097/MEG.0000000000001415
– ident: e_1_2_8_47_1
  doi: 10.1016/j.jamda.2019.12.012
– ident: e_1_2_8_11_1
  doi: 10.1213/ANE.0b013e3181eac1c9
– ident: e_1_2_8_14_1
  doi: 10.1016/j.jamda.2013.11.025
– ident: e_1_2_8_36_1
  doi: 10.1152/ajpendo.00183.2012
– ident: e_1_2_8_41_1
  doi: 10.1002/hep.27717
– ident: e_1_2_8_38_1
  doi: 10.1016/S0168-8278(97)80315-7
– ident: e_1_2_8_6_1
  doi: 10.1097/00075197-200301000-00012
– ident: e_1_2_8_26_1
  doi: 10.1007/s00535-014-0964-9
– ident: e_1_2_8_37_1
  doi: 10.1016/j.jhep.2016.06.007
– ident: e_1_2_8_4_1
  doi: 10.1093/gerona/glu246
– ident: e_1_2_8_24_1
  doi: 10.1111/hepr.12873
– ident: e_1_2_8_34_1
  doi: 10.7600/jpfsm.4.111
– ident: e_1_2_8_46_1
  doi: 10.1007/s12603-019-1287-6
– ident: e_1_2_8_35_1
  doi: 10.1016/j.jhep.2016.07.040
– ident: e_1_2_8_29_1
  doi: 10.1038/ctg.2015.31
– ident: e_1_2_8_31_1
  doi: 10.1016/j.ejrad.2018.01.025
– ident: e_1_2_8_39_1
  doi: 10.1038/ctg.2016.33
– ident: e_1_2_8_21_1
  doi: 10.1016/j.clnu.2019.04.023
– ident: e_1_2_8_12_1
  doi: 10.1002/jcsm.12212
– ident: e_1_2_8_44_1
  doi: 10.1371/journal.pone.0186990
– ident: e_1_2_8_8_1
  doi: 10.1016/j.bbrc.2003.07.016
– ident: e_1_2_8_27_1
  doi: 10.1016/j.jhep.2015.02.031
– ident: e_1_2_8_7_1
  doi: 10.1007/s13539-012-0069-3
SSID ssj0017024
Score 2.5041215
Snippet Aim Sarcopenia has a high prevalence and can be an adverse predictor in patients with chronic liver diseases (CLDs). We sought to assess the prevalence of...
AimSarcopenia has a high prevalence and can be an adverse predictor in patients with chronic liver diseases (CLDs). We sought to assess the prevalence of...
Sarcopenia has a high prevalence and can be an adverse predictor in patients with chronic liver diseases (CLDs). We sought to assess the prevalence of...
SourceID proquest
crossref
wiley
SourceType Aggregation Database
Enrichment Source
Index Database
Publisher
StartPage 957
SubjectTerms cut‐off value
handgrip strength
Hepatocellular carcinoma
liver
Liver diseases
Medical prognosis
Mortality
Prognosis
Sarcopenia
Skeletal muscle
skeletal muscle mass
Title Reduced handgrip strength predicts poorer survival in chronic liver diseases: A large multicenter study in Japan
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fhepr.13679
https://www.proquest.com/docview/2568002084
https://www.proquest.com/docview/2535107006
Volume 51
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fS-QwEB7Eg8MXPe88XH-R43xRqLTbtNkcvqw_lkVQjuUEX46SxIket3RL233xr79M2q56iKBvhU5Im2RmviRfvgDsh7HFFEN0yE2qgCuNgcQoChIUIhbKJQi_dHF5lY6v-cVNcrMEx91ZmEYfYrHgRp7h4zU5uNLVEye_x6Ikkpag03tE1iJENFloR0UibG-0HaRBGvO01SYlGs9j0efZ6BFiPgWqPtOM1uB3940NweTv0bzWR-bhP_nG9_7EJ1htISgbNmNmHZYw_wwfL9tN9i9QTEjOFW8ZLarfuaDC6EBJflffs6Ikq7pixWxWYsmquYs0bqyyPzkzjcwumxLTg7UbP9UPNmRTYpszT10kLiiVI1FbKnThcnW-Adej81-n46C9mCEwPA1lkGrTN6gSldyalCspNSJNdkNpdKRs7LIeupSImlsZ2YjbEK22YhAJ0rLom_grLOezHDeBCWlJxEq4ebLmkbRa94XWCdcuEHOjeQ8Oug7KTKtaTpdnTLNu9kJNmPkm7MH3hW3RaHW8aLXT9XPW-muVOeDnkfPAVfht8dp5Gm2fqBxnc7KJXQATLkz14NB36iu1ZOPznxP_tPUW421Y6RNpxpPYdmC5Lue461BPrffgw_Dk7GS050f5P9WfARk
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VIgEX3oiFAkbAAaRUeTjxulIPFW21fWyFVq3UW4jdcYtYZaMkKwT_qX-lvwmP42wLQkgceuAWKeM8bM_nGfvzZ4C3YWIwwxBt5CaLgBcKA4lRFKQoRCIKO0C4qYvxQTY64rvH6fESnPd7YTp9iMWEG3mGw2tycJqQvuLlZ1jVxNIS0nMq9_D7N5uxNes7m7Z538Xx9tbhx1HgDxUINM9CGWRKxxqLtEhPdMYLKRUiJWqh1CoqTGIRGy2co-JGRibiJkSjjBhGgnQYYp3Y596Am3SEOEn1b04WalWRCP0ZusMsyBKeeTVUIg5dfuuv499lUHs1NHZj2_Y9uOhrpaO0fF2dt2pV__hNMPK_qbb7cNdH2Wyjc4sHsITlQ7g19jyCR1BNSLEWTxitG5xa3GS0Z6Y8bc9YVZNV27BqNquxZs3cgql1R_alZLpTEmZTIrMwv7bVrLENNiVCPXPsTKK7UjnS7aVCuzYcKR_D0bX87xNYLmclPgUmpCGdLjFMhOKRNErFQqmUKzvWcK34AN73PSLXXpidzgeZ5n2CRk2WuyYbwJuFbdXJkfzRaqXvWLmHpCa3sa1LDob2ha8Xty2Y0ApRUeJsTjaJxWhhkXgAH1wv-stb8tHWp4m7evYvxq_g9uhwvJ_v7xzsPYc7MXGEHGdvBZbbeo4vbJDXqpfOtRh8vu5O-RMqJF5b
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Nb9QwEB2VIlVc-EZdKGAEHEBKlQ8nXiNxqNiuti2tqhWVeguxd9wiVtkoyQrBb-Kv8J_wOM62IITEoQdukTK2E9vzPLafnwFehInBDEO0kZssAl4oDCRGUZCiEIko7ADhli4Oj7LJCd8_TU_X4Ht_FqbTh1gtuJFnOLwmB69m5pKTn2NVE0lLSE-pPMCvX-yErXm7N7Kt-zKOx7sf3k0Cf6dAoHkWyiBTOtZYpEU60xkvpFSINE8LpVZRYRIL2GjRHBU3MjIRNyEaZcQwEiTDEOvE5nsNrlNedFHEaLoSq4pE6K_QHWZBlvDMi6ESb-jiW38d_i5i2suRsRvaxrfgR18pHaPl8_ayVdv62296kf9Lrd2Gmz7GZjudU9yBNSzvwsahZxHcg2pKerU4Y7RrcGZRk9GJmfKsPWdVTVZtw6rFosaaNUsLpdYZ2aeS6U5HmM2JysL8zlbzhu2wOdHpmeNmEtmV0pFqLyXat8FIeR9OruR_H8B6uShxE5iQhlS6xDARikfSKBULpVKu7EjDteIDeNV3iFx7WXa6HWSe99MzarLcNdkAnq9sq06M5I9WW32_yj0gNbmNbN3UYGgLfLZ6baGE9oeKEhdLskksQguLwwN47TrRX0rJJ7vHU_f08F-Mn8LG8Wicv987OngEN2IiCDnC3hast_USH9sIr1VPnGMx-HjVffInoWNdCg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Reduced+handgrip+strength+predicts+poorer+survival+in+chronic+liver+diseases%3A+A+large+multicenter+study+in+Japan&rft.jtitle=Hepatology+research&rft.au=Nishikawa%2C+Hiroki&rft.au=Shiraki%2C+Makoto&rft.au=Hiramatsu%2C+Akira&rft.au=Hara%2C+Nagisa&rft.date=2021-09-01&rft.pub=Wiley+Subscription+Services%2C+Inc&rft.issn=1386-6346&rft.eissn=1872-034X&rft.volume=51&rft.issue=9&rft.spage=957&rft.epage=967&rft_id=info:doi/10.1111%2Fhepr.13679&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1386-6346&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1386-6346&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1386-6346&client=summon